• In January 2024, HMP Global, in partnership with the Wound Care Collaborative Community (WCCC), announced the hosting of the inaugural Driving Innovation in Wound Care Summit co-located with the Symposium on Advanced Wound Care (SAWC).

• In January 2022, SWM and Convatec Inc. entered into a multi-year supply agreement in conjunction with their amicable resolution of the pending legal process between the companies. Through this agreement, both companies partnered with Scapa to deliver advanced products.

In this report, the Unna Boot Market has been segmented by Raw Material, Application, End User, and Geography.

Unna Boot Market, Segmentation by Raw Material

The Unna Boot Market has been segmented by Raw Material into Zinc Oxide and Zinc and Calamine.

Zinc Oxide

Zinc oxide-based Unna boots dominate the market, accounting for nearly 65% of global sales. This dominance is due to its anti-inflammatory, antiseptic, and wound-healing properties, making it highly effective for treating venous leg ulcers and dermatitis. The material also provides moisture control for chronic wounds.

Zinc and Calamine

Zinc and calamine formulations represent approximately 35% of the Unna Boot Market. Calamine enhances the soothing and anti-itch properties of the boot, making it suitable for patients with high skin sensitivity. It is often chosen for long-term compression therapy in dermatological care.

Unna Boot Market, Segmentation by Application

The Unna Boot Market has been segmented by Application into Venous Leg Ulcers, Lymphedema, Eczema and Others.

Venous Leg Ulcers

Venous leg ulcers account for nearly 60% of the Unna Boot Market, making it the most common application. The compression and healing properties of Unna boots are highly effective in managing chronic venous insufficiency and ulceration, offering relief and faster wound closure.

Lymphedema

Lymphedema treatment represents about 20% of the market share. Unna boots are used for their ability to provide consistent compression, which helps reduce fluid retention and limb swelling associated with this chronic condition.

Eczema

Eczema accounts for approximately 12% of applications. Patients with severe dermatitis or inflamed skin benefit from the soothing, protective, and anti-itch properties of zinc- and calamine-based Unna boots, which aid in managing flare-ups.

Others

The 'Others' category makes up around 8% and includes uses in minor burns, post-surgical wound care, and diabetic ulcers. The Unna boot is valued for its versatile wound management benefits in clinical and outpatient settings.

Unna Boot Market, Segmentation by Distributional Channel

The Unna Boot Market has been segmented by Distributional Channel into Online Retail and Offline Retail.

Online Retail

Online retail channels account for around 40% of the Unna Boot Market, driven by the growing popularity of e-commerce platforms and the ease of access to specialized wound care products. Consumers increasingly prefer convenient home delivery and competitive pricing offered by online suppliers.

Offline Retail

Offline retail dominates the market with a share of approximately 60%, primarily through pharmacies, hospital supply stores, and medical equipment retailers. This channel is trusted for product authenticity and immediate availability, particularly in clinical and long-term care settings.

Unna Boot Market, Segmentation by End User

The Unna Boot Market has been segmented by End User into Hospitals, Clinics, Homecare Settings, and Others.

Hospitals

Hospitals represent the largest share of the Unna Boot Market at nearly 45%, owing to the high volume of wound care cases and advanced treatment protocols. Unna boots are routinely used in post-operative care, chronic wound management, and venous ulcer treatment.

Clinics

Clinics account for around 25% of the market and are key users of Unna boots for outpatient care and minor wound treatment. They provide cost-effective, localized care solutions, making these facilities critical for early-stage intervention.

Homecare Settings

Homecare settings contribute to approximately 20% of the market, driven by the growing trend of home-based chronic wound management. Unna boots are preferred here for their ease of use and effectiveness in self-care environments.

Others

The 'Others' segment holds the remaining 10%, encompassing rehabilitation centers, nursing homes, and military medical units. These facilities use Unna boots as part of comprehensive care for immobile or long-term patients.

Unna Boot Market, Segmentation by Geography

In this report, the Unna Boot Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Unna Boot Market Share (%), by Geographical Region

North America

North America holds the largest market share, contributing approximately 40% of the global Unna Boot Market. This dominance is driven by well-established healthcare infrastructure, a high prevalence of chronic venous disorders, and strong adoption in hospital and homecare settings.

Europe

Europe follows closely with a share of around 30%, fueled by the presence of advanced wound care practices and a rising elderly population. Countries like Germany and the UK are prominent contributors due to robust reimbursement policies and clinical usage.

Asia Pacific

Asia Pacific is emerging as a rapidly growing region, accounting for nearly 18% of the market. Factors such as increasing healthcare investments, expanding medical tourism, and a growing awareness of wound management solutions are propelling demand.

Middle East and Africa

The Middle East and Africa hold a modest share of about 7%, limited by lower healthcare access in rural zones. However, growth is expected due to rising healthcare initiatives and expanding hospital infrastructure in the Gulf Cooperation Council (GCC) nations.

Latin America

Latin America contributes nearly 5% to the Unna Boot Market, driven by gradual improvements in wound care awareness and public health funding. Countries such as Brazil and Mexico are showing increased adoption of compression therapy products.

This report provides an in depth analysis of various factors that impact the dynamics of Global Unna Boot Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Rising chronic wounds cases
• Technological advancements in materials

• Increasing diabetic foot ulcers - Increasing diabetic foot ulcers are a major driver of growth in the Unna boot market. As the global prevalence of diabetes continues to rise, complications such as foot ulcers are becoming more widespread, particularly among aging populations. Diabetic foot ulcers are often chronic, difficult to heal, and require specialized care to prevent infections, amputations, and further health deterioration. This has significantly elevated the demand for effective wound management solutions like Unna boots.

  Unna boots, which consist of a compression bandage impregnated with zinc oxide and other soothing agents, are widely used in the treatment of venous leg ulcers and diabetic foot wounds. Their ability to provide constant, gentle compression while maintaining a moist wound environment makes them ideal for promoting healing and reducing inflammation. As healthcare providers focus more on managing chronic wounds efficiently, Unna boots are becoming an integral component of diabetic foot ulcer treatment protocols.

  The growing burden of diabetes-related complications is also driving awareness and early intervention strategies in wound care. Hospitals, clinics, and home healthcare providers are increasingly adopting Unna boots due to their proven effectiveness, ease of application, and compatibility with multidisciplinary care approaches. The rise in outpatient and home-based care further supports their adoption, as they offer a cost-effective and clinically validated solution for managing slow-healing wounds.

Restraints

• Low awareness and limited usage in emerging markets
• Limited reimbursement policies

• Availability of alternative treatments - Availability of alternative treatments is a key restraint impacting the growth of the Unna boot market. While Unna boots are widely recognized for their effectiveness in managing chronic wounds and venous leg ulcers, they face stiff competition from a variety of advanced wound care products. Options such as multilayer compression bandages, hydrocolloid dressings, foam dressings, negative pressure wound therapy, and bioengineered skin substitutes offer different benefits, often preferred for their convenience, faster healing outcomes, or enhanced comfort.

  Healthcare professionals may opt for these alternatives based on specific patient needs, wound types, or institutional protocols. In some cases, the newer therapies are perceived as more modern or better supported by clinical research, leading to a shift in prescribing patterns. As wound care becomes increasingly personalized, the presence of diverse treatment options makes it challenging for Unna boots to maintain market dominance, especially in settings focused on innovation or where funding supports premium solutions.

Opportunities

• Development of innovative products
• Growing healthcare expenditure

• Focus on preventive healthcare measures - Focus on preventive healthcare measures presents a valuable opportunity for growth in the Unna boot market. As healthcare systems worldwide shift from reactive treatment models to proactive prevention strategies, there is increased emphasis on early identification and management of chronic conditions that can lead to complications such as venous leg ulcers and diabetic foot wounds. Unna boots, known for their ability to prevent the progression of minor wounds into more severe ulcers, align well with this evolving healthcare paradigm.

  Preventive care programs targeting patients with chronic venous insufficiency, peripheral artery disease, and diabetes are becoming more widespread, particularly in primary care and community health settings. These programs often include routine screening, wound assessments, and compression therapy as standard components. The inclusion of Unna boots in such protocols offers a cost-effective and clinically reliable option to minimize the risk of wound deterioration, reduce hospital admissions, and improve patient outcomes.

Key players in Global Unna Boot Market include:

• Cardinal Health, Inc
• ConvaTec Inc
• Medline Industries, Inc
• McKesson Medical-Surgical Inc
• GF Health Products, Inc
• BSN Medical
• Andover Healthcare
• Derma Sciences
• Dynarex Corporation
• American Medicals

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis